Biocryst Pharmaceuticals (BCRX) Research & Development: 2010-2015
Historic Research & Development for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $20.1 million.
- Biocryst Pharmaceuticals' Research & Development rose 53.94% to $20.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $72.2 million, marking a year-over-year increase of 48.14%. This contributed to the annual value of $51.8 million for FY2014, which is 23.49% up from last year.
- As of Q3 2015, Biocryst Pharmaceuticals' Research & Development stood at $20.1 million, which was up 21.44% from $16.5 million recorded in Q2 2015.
- Biocryst Pharmaceuticals' 5-year Research & Development high stood at $20.1 million for Q3 2015, and its period low was $7.2 million during Q2 2013.
- For the 3-year period, Biocryst Pharmaceuticals' Research & Development averaged around $13.6 million, with its median value being $14.3 million (2013).
- Its Research & Development has fluctuated over the past 5 years, first plummeted by 39.28% in 2011, then skyrocketed by 86.43% in 2015.
- Quarterly analysis of 4 years shows Biocryst Pharmaceuticals' Research & Development stood at $15.2 million in 2011, then reached $15.5 million in 2013, then climbed by 19.68% to $18.5 million in 2014, then skyrocketed by 53.94% to $20.1 million in 2015.
- Its last three reported values are $20.1 million in Q3 2015, $16.5 million for Q2 2015, and $17.1 million during Q1 2015.